Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups
Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559)
09/2005
09/28/2005EP1578748A1 Tetrahydro-4h-pyrido [1, 2-a] pyrimidines and related compounds useful as hiv integrase inhibitors
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578742A1 Process for preparing optically pure active compounds
09/28/2005EP1578723A2 Process for the preparation of oxazolidinones and method of use thereof
09/28/2005EP1578429A2 Protease inhibitors
09/28/2005EP1578424A2 Substituted 1-benzoyl-3-cyano-pyrrolo 1,2-a] quinolines and analogs as activators of caspases and inducers of apoptosis
09/28/2005EP1361880B1 6-substituted pyrido-pyrimidines
09/28/2005EP1345937B1 Quinuclidine carbamate derivatives and their use as m3 antagonists
09/28/2005EP1243583B1 Heterocyclic compounds having sulfonamide groups
09/28/2005EP1225173B1 Naphthyridine derivatives
09/28/2005EP1086099B1 Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
09/28/2005EP1000085B1 Treatment of insulin resistance with growth hormone secretagogues
09/28/2005CN1675218A Novel tricyclic spiropiperidines or spiropyrrolidines
09/28/2005CN1675215A Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists
09/28/2005CN1675210A Substituted 2, 4-dihydro-pyrrolo[3, 4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors
09/28/2005CN1675209A Dihydropyrazolopyridine compounds
09/28/2005CN1675208A Novel fused imidazole derivative
09/28/2005CN1675207A 6-alkoxy-pyrido-pyrimidines as p-38 MAP kinase inhibitors
09/28/2005CN1675181A 2, 3-dihydro-isoindol-1-ones with MAO-B inhibiting activity
09/28/2005CN1674894A Ether substituted imidazopyridines
09/28/2005CN1673219A Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them
09/28/2005CN1220681C Indole derivatives as XA factor inhibitors
09/27/2005US6949662 Cis-substituted aminocyclopropane derivative
09/27/2005US6949653 A chemical intermediate reaction by starting 2,6-diaminopyridine with malic acid and sulfuric acid, salt formation, hydroxylation, chlorination, dehydroxylation, reduction, esterification
09/27/2005US6949652 crystal structured nitrogen compounds, used as p38 MAP kinase inhibitors, for prophylaxis of inflammation, osteoarthritis, arthritis, cancer, cardiovascular disorders and autoimmune diseases
09/27/2005US6949650 Process for the racemization of 1-benzyl-4-(4-fluorophenyl)-3-hydroxymethyl-1,2-3,6-tetrahydropyridine to be used as intermediate in the synthesis of paroxetine
09/27/2005US6949649 used as immunomodulators, for inducing cytokine biosynthesis in animals, and in the treatment of diseases, including viral and neoplastic diseases
09/27/2005US6949648 Condensed pyrazole derivatives, process for producing the same and use thereof
09/27/2005US6949646 Nitrogen compounds such as 2-Butyl-1-(2-methylpropyl)-1H-tetrazolo[1,5-a]imidazo[4,5-c][1,8]naphthyridine, used to induce biosynthesis of cytokines such as interferons and tumor necrosis factors, or for prophylaxis of viral diseases
09/27/2005US6949643 Thiazolopytimidines and their use as modulators of chemokine receptor activity
09/27/2005US6949583 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method of preparing same and compositions containing same
09/27/2005US6949580 Anticancer agents; restenosis; antiinflammatory agents; cardiovascular disorders
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949571 Novel compound having an excellent AMPA receptor inhibitory action and/or kainate inhibitory action. A compound represented by the following formula, a salt thereof or hydrates thereof.
09/27/2005US6949569 Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
09/27/2005US6949564 NPY-5 antagonists
09/27/2005US6949563 (2-carboxamido)(3-amino)thiophene compounds
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/27/2005US6949560 Imidazo-substituted compounds as p38 kinase inhibitors
09/27/2005US6949550 Substituted amino methyl factor Xa inhibitors
09/27/2005US6949541 Substituted piperidines, medicaments containing these compounds, and methods for the production thereof
09/27/2005US6949540 Substituted pyrazoles
09/27/2005US6949534 An amide compound containing a very late antigen of activation-4 (VLA-4) specifity determinanat which doesn't impart significant IIb/IIIa activity; antiinflammatory agent and useful for treating autoimmune disorders
09/27/2005CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
09/22/2005WO2005087846A1 Supramolecular complex of pyridylnaphthalenediimide with zinc porphyrin dendrimer having multiplicity of artificial photosynthetic reaction center
09/22/2005WO2005087769A1 Fused ring azadecalin glucocorticoid receptor modulators
09/22/2005WO2005087768A1 Hiv integrase inhibitors
09/22/2005WO2005087767A1 Hiv integrase inhibitors
09/22/2005WO2005087766A1 Hiv integrase inhibitors
09/22/2005WO2005087750A1 Ion channel modulators
09/22/2005WO2005087746A1 Benzazepine derivatives for the treatment of neurological and psychiatric disorders
09/22/2005WO2005087745A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005WO2005087232A1 Bicyclic modulators of androgen receptor function
09/22/2005WO2005087227A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005WO2005086808A2 NOVEL DICATIONIC IMIDAZO[1,2-a]PYRIDINES AND 5,6,7,8-TETRAHYDRO-IMIDAZO[1,2a]PYRIDINES AS ANTIPROTOZOAL AGENTS
09/22/2005WO2005086700A2 Hiv integrase inhibitors
09/22/2005WO2005070927A3 1,2,4-triazolo[1,5-a] pyridines as gastric acid secretion inhibitors
09/22/2005WO2005070871A3 Amino alcohol derivatives and their activity as renin inhibitors
09/22/2005WO2005056524A3 Therapeutic agents useful for treating pain
09/22/2005WO2005023759A3 Heterocyclic inhibitors of mek and methods of use thereof
09/22/2005US20050209488 Reacting 1-amino-2-hydroxy-indene with a first protecting group containing a leaving group, followed by acetylation to prepare a protected intermediate, reacting with trifluoromethyl substituted ketone, then with metal oxide, hydrolysis, esterification, reaction with amino-picoline
09/22/2005US20050209456 Vascular endothelial growth factor; tyrosine kinase inhibitor; angiogenesis inhibitor; anticancer agents
09/22/2005US20050209276 Etherification, dehalogenation; filtration, crystallization; bactericides
09/22/2005US20050209273 Neuroprotectants, analgesics or anticonvulsants
09/22/2005US20050209271 Form of renzapride hydrochloride hydrate and uses thereof
09/22/2005US20050209269 3-(carboxy or carbamoyl)-5-amino-1H-pyrrolo(2,3-b)pyridines; cancer, Alzheimer's disease, viral infections, autoimmune diseases and neurodegenerative disorders; chemical libraries of these compounds
09/22/2005US20050209268 Administering optionally hydrogenated 2-alkyl-1-(alkylsulfonylalkyl)imidazo[4,5-c]quinoline-4-amines to induce biosynthesis of cytokines such as IFN-alpha and/or TNF-alpha; treating viral diseases and neoplastic diseases
09/22/2005US20050209267 Thioether substituted imidazoquinolines
09/22/2005US20050209264 Pyridoindole diamido compound substituted with a nitrogen heterocycle and a pyridoindole diamine compound substituted with a nitrogen heterocycle; treating depression and anxiety
09/22/2005US20050209255 Compositions useful as inhibitors of protein kinases
09/22/2005US20050209253 Corticotropin releasing factor (CRF) receptor antagonists; nervous system disorders, ischemia, gastrointestinal disorders, hypertension, eating disorders, sleep disorders; e.g. 2-(1-[7-(2,6-dibromo-4-trifluoromethyl-phenyl)-2,5,6-trimethyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-piperidin-2-yl)-ethanol
09/22/2005US20050209246 Prodrugs of piperazine and substituted piperidine antiviral agents
09/22/2005US20050209233 Neuropeptide Y5 (NPY-5) receptor antagonists or agonists; eating disorders, diabetes dyslipidemia, hypertension, and sleep disorders; pyridazin-3-ylamino-substituted dibenzothiophenes and S-oxides thereof
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209213 Quinoline compound
09/22/2005US20050209197 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds
09/22/2005US20050208582 Pyrazole compounds and pharmaceutical compositions comprising the compound
09/22/2005US20050207981 Compositions and methods for determining substrate specificity of hydrolytic enzymes
09/22/2005CA2558899A1 Fused ring azadecalin glucocorticoid receptor modulators
09/22/2005CA2558391A1 Novel amido-substituted hydroxy-6-phenylphenanthridines and their use as pde4 inhibitors
09/22/2005CA2558224A1 Ion channel modulators
09/22/2005CA2557926A1 Hiv integrase inhibitors
09/22/2005CA2557904A1 Hiv integrase inhibitors
09/22/2005CA2557545A1 Substituted 5,12-diaza-benzoanthracene analogues
09/22/2005CA2555867A1 Arylalkylamino-substituted quinazoline analogues
09/22/2005CA2554554A1 Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2a]pyridines as antiprotozoal agents
09/21/2005EP1577311A1 Salts of a pyridazino aquinoline derivative and use for the treatment of pain
09/21/2005EP1577302A1 Novel ethylenediamine derivatives
09/21/2005EP1577301A1 Diamine derivatives
09/21/2005EP1576159A1 The gene cluster involved in safracin biosynthesis and its uses for genetic engineering
09/21/2005EP1575963A1 Therapeutic agents
09/21/2005EP1575956A1 Fungicides based on nitrogen-containing heterocycles
09/21/2005EP1575952A1 Synthesis of heteroaryl acetamides
09/21/2005EP1575951A1 Heterocyclic compounds, methods of making them and their use in therapy
09/21/2005EP1575950A1 [1,7]naphthyridines as pde4 inhibitors
09/21/2005EP1575949A1 Fungicides
09/21/2005EP1575948A1 Pyridodiazines as plant fungicides
09/21/2005EP1575947A1 2-oxopyridin-3-yl thia(di)azole derivatives for use in the treatment of cell proliferation and apoptosis related diseases
09/21/2005EP1575934A1 Carbazole derivatives and their use as npy-5 antagonists
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
1 ... 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 ... 646